The epidemiology of penicillin resistance in Streptococcus pneumoniae

K R Forward1

  • 1Division of Microbiology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.

Seminars in Respiratory Infections
|September 29, 1999
PubMed

Insights

Penicillin-resistant Streptococcus pneumoniae strains emerged in 1965 and rapidly spread worldwide. This resistance complicates treatment for serious infections like meningitis and otitis media.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Streptococcus pneumoniae is typically susceptible to penicillin and other common antibiotics.
  • Penicillin-resistant strains first identified in 1965, initially with minor resistance.
  • Widespread global dissemination of penicillin resistance observed since the 1970s.

Purpose of the Study:

  • To document the historical emergence and global spread of penicillin resistance in Streptococcus pneumoniae.
  • To highlight the concurrent development of resistance to other antibiotic classes.
  • To underscore the clinical implications of widespread resistance for treating pneumococcal infections.

Main Methods:

  • Historical review of reported pneumococcal resistance data.
  • Tracking the geographical spread of resistant strains.
  • Correlating resistance trends with antibiotic usage patterns (implied).

Main Results:

  • Penicillin resistance identified in 1965, becoming globally prevalent by the late 1970s.
  • Over 10% resistance reported in multiple countries by the early 1980s.
  • Significant increases in resistance noted in several countries in recent decades.
  • Co-resistance to multiple antibiotic classes (cephalosporins, macrolides, tetracyclines, etc.) has developed.
  • Highly resistant strains pose challenges for treating meningitis and otitis media.

Conclusions:

  • Penicillin resistance in Streptococcus pneumoniae has spread rapidly worldwide.
  • Acquired resistance can disseminate globally through virulent clones.
  • Co-resistance to other antibiotics is a growing concern.
  • Highly resistant pneumococci significantly challenge effective patient treatment.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...